Prediction of biological targets using probabilistic neural networks and atom-type descriptors.
Prediction of biological targets for molecules from their chemical structures is beneficial for generating focused libraries, selecting compounds for screening, and annotating biological activities for those compounds whose activities are unknown. We studied the ability of a probabilistic neural network (PNN), a variant of normalized radial basis function (RBF) neural networks, to predict biological activities for a set of 799 compounds having activities against seven biological targets. The compounds were taken from the MDDR database, and they were carefully selected to comprise distinct biological activities and diverse structures. The structural characteristics of compounds were represented by a set of 24 atom-type descriptors defined by 2D topological chemical structures. The modeling was done in two ways: (1). compounds having one certain activity were discriminated from those not having that activity and (2). all compounds were classified into seven biological classes. In both cases, around 90% of the compounds were correctly classified. Further validation of the modeled PNNs was done with 26 317 compounds having biological activities against various targets except for the seven targets used for modeling, and 67-98% compounds were correctly classified depending upon the targets. A PNN trains much more quickly than widely used neural networks such as a feed-forward neural network with error back-propagation. Calculation of atom-type descriptors is easy even for a large-size chemical library. Combination of PNN and atom-type descriptors thus provides a powerful way to predict biological activities from structural information.
Niwa
Tomoko
T
Discovery Research Laboratories, Nippon Shinyaku Co, Ltd 14, Nishinosho-Monguchi-cho, Kisshoin, Minami-ku, Kyoto, 601-8550, Japan. t.niwa@po.nippon.shinyaku.co.jp
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000737:chemistry; D002257:Carbonic Anhydrase Inhibitors; D016333:HIV Protease / Q000737:chemistry; D017320:HIV Protease Inhibitors / Q000737:chemistry; D006633:Histamine Antagonists / Q000737:chemistry; D016571:Neural Networks, Computer; D011374:Progesterone / Q000037:antagonists & inhibitors; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors; D021281:Quantitative Structure-Activity Relationship; D018100:Receptors, Histamine H3 / Q000737:chemistry; D058830:Serotonin 5-HT2 Receptor Antagonists
D000806:Angiotensin-Converting Enzyme Inhibitors; D002257:Carbonic Anhydrase Inhibitors; D017320:HIV Protease Inhibitors; D006633:Histamine Antagonists; D018100:Receptors, Histamine H3; D058830:Serotonin 5-HT2 Receptor Antagonists; D011374:Progesterone; D011505:Protein-Tyrosine Kinases; D016333:HIV Protease